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Abstract
Background: Maternal perception of reduced fetal movement (RFM) is associated with increased risk of stillbirth and fetal
growth restriction (FGR). DFM is thought to represent fetal compensation to conserve energy due to insufficient oxygen and
nutrient transfer resulting from placental insufficiency. To date there have been no studies of placental structure in cases of
DFM.
Objective: To determine whether maternal perception of reduced fetal movements (RFM) is associated with abnormalities
in placental structure and function.
Design: Placentas were collected from women with RFM after 28 weeks gestation if delivery occurred within 1 week.
Women with normal movements served as a control group. Placentas were weighed and photographs taken. Microscopic
structure was evaluated by immunohistochemical staining and image analysis. System A amino acid transporter activity was
measured as a marker of placental function. Placentas from all pregnancies with RFM (irrespective of outcome) had
greater area with signs of infarction (3.5% vs. 0.6%; p,0.01), a higher density of syncytial knots (p,0.001) and greater
proliferation index (p,0.01). Villous vascularity (p,0.001), trophoblast area (p,0.01) and system A activity (p,0.01) were
decreased in placentas from RFM compared to controls irrespective of outcome of pregnancy.
Conclusions: This study provides evidence of abnormal placental morphology and function in women with RFM and
supports the proposition of a causal association between placental insufficiency and RFM. This suggests that women
presenting with RFM require further investigation to identify those with placental insufficiency.
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Introduction
There has been little reduction in stillbirth rates in high-income
countries over the past 20 years, with the incidence of stillbirth in
the UK and the USA approximately ,5–6 per 1,000 live births
[1,2]. This results in part from a lack of sufficiently sensitive and
specific methods of identifying women at highest-risk of stillbirth
[3]. One clinical sign related to stillbirth is a reduction in
maternally-perceived fetal movements. The majority of stillbirths
are preceded by a period of reduced fetal movements (RFM) for 3–
4 days and stillbirth rates are increased in women after RFM
[4,5,6,7]. However, the use of RFM as a screening tool to identify
women at increased risk of stillbirth is contentious; this is in part
related to the lack of pathophysiological evidence linking RFM to
stillbirth.
Both pathological and non-pathological conditions are associ-
ated with RFM [8]; the most common pathological association
with RFM is small for gestational age (SGA) or fetal growth
restriction (FGR), which affects approximately 20% of pregnancies
with RFM [9,10,11]. The link between RFM, SGA/FGR and
stillbirth is proposed to be via placental insufficiency, where
impaired placental function leads to oxygen and nutrient
deprivation resulting in fetal compensation and impaired fetal
growth. Ongoing placental insufficiency leads to RFM and
ultimately fetal decompensation and death [12]. This hypothesis
is supported by observations of relative hypoxaemia and
acidaemia in fetuses after RFM compared to normal movements
[13].
In FGR/SGA the placenta exhibits features of abnormal villous
structure, reduced vascularity [14,15], aberrant cell turnover
[16,17,18,19], as well as a reduced capacity for nutrient exchange
[20,21]. There are no similar studies investigating these indices of
placental cell turnover and function in cases of stillbirth, decreased
villous vascularity is evident in stillbirth with chronic fetal vascular
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34851insufficiency [22]. However, no study to date has investigated
whether there is evidence of abnormal placental structure or
function in RFM. The purpose of this study was to test the
hypothesis that placentas from women who had presented with
RFM in the week before delivery would have placentas with
abnormal morphology and function.
Methods
Placental collection and Tissue Processing
Ethical approval was obtained from Oldham and North West
Research Ethics Committees (Refs 08/H1011/83 and 08/H1010/
55) and all participants provided written informed consent.
Tissue classified as normal was collected from women with
uncomplicated pregnancies delivering at term with no history of
RFM (n=36). All women at St Mary’s Hospital receive standard
information recommending they present to the maternity service if
they perceive a reduction in their babies’ movements. From
August 2009 until October 2010 women presenting with RFM
after 28 weeks gestation were recruited from the Maternity Day
Unit (n=305). RFM was defined as subjective maternal
perception of RFM for at least 12 hours [23]. Women were
excluded if there was a fetal anomaly, multiple pregnancy or
abnormal fetal heart rate on cardiotocography. If participants with
RFM delivered within 7 days of presentation (n=36), their
placenta was collected. This seven day cut-off was arrived at
empirically to allow a temporal association between RFM and
placental pathology. For all women recruited the pregnancy
outcome was recorded. Poor pregnancy outcome was defined as
stillbirth, pre-term birth, small for gestational age infant defined as
an individualised birthweight centile ,10
th or term admission to
the neonatal intensive care unit. These were chosen as infants
stillborn after RFM were all SGA [24], and infants subject to
severe intra-uterine compromise might not die but instead be
delivered prematurely or require neonatal intensive care [25].
Placentas were collected from RFM and normal pregnancies
within 30 minutes of birth. Placentas from either group were
collected during the same time period and an identical sampling
strategy used. Photographs of the maternal and fetal sides of the
placenta were taken and the placenta was weighed, before and
after removal of the membranes and cord. Biopsies of villous tissue
(approximately 1 cm
3) were dissected from the centre and edge of
the placenta and a point midway in between. Tissue was fixed in
4% neutral buffered formalin for 24 hours and wax embedded. To
analyse activity of the System A amino acid transport system, three
1c m
3 samples of villous tissue were randomly taken and placed in
1:1 Dulbecco’s Modified Eagle Medium (DMEM): control
Tyrode’s buffer [135.0 mM/L NaCl, 5.0 mM/L KCl, 1.8 mM/
L anhydrous CaCl2, 1.0 mM/L MgCl2 hexahydrate, 10.0 mM/L
HEPES, 5.6 mM/L D-glucose (pH 7.4)] for immediate analysis.
Unless otherwise stated, reagents were acquired from Sigma-
Aldrich (Poole, UK).
Immunohistochemistry
Placental cell turnover, structure and vascularity were assessed
using antibodies specific for Ki67 (Dako, Ely, Cambridgeshire,
UK; 0.16 mg/ml), cytokeratin-M30 (Roche, London, UK;
0.66 mg/ml), cytokeratin 7 (Dako; 0.9 mg/ml) and CD31 (Dako;
0.16 mg/ml). Negative controls were performed using non-
immune mouse IgG (Dako) at matching concentrations to the
primary antibody.
Slides were dewaxed and antigen retrieval performed by
microwaving the sections for 10 minutes in 0.01 M sodium citrate
buffer. Endogenous peroxidase was quenched with 3% H2O2
before non-immune block (NIB, 10% goat serum, 2% human
serum, in TBS-Tween 0.1% (Biorad Laboratories Ltd, Hemel
Hempstead, Hertfordshire, UK) was applied for 30 minutes.
Primary antibody/negative control diluted in NIB was incubated
overnight at 4uC. Sections were then exposed to the biotinylated-
goat anti-mouse IgG (4 mg/ml) for 30 minutes, followed by avidin
peroxidase (5 mg/ml) for 30 minutes. Positive antibody binding
was revealed by application of 3,39-diaminobenzidine. Slides were
counterstained, dehydrated and cleared before coverslips were
applied with DPX (Raymond Lamb, London, UK).
Haematoxylin and eosin staining was performed to allow
quantification of syncytial knots. Dewaxed and rehydrated sections
were stained with Harris’s haematoxylin for 10 minutes before
differentiation in acid-alcohol. Slides were stained with eosin for
2 minutes, rinsed in cold tap water, and dehydrated and mounted
as described above.
Images were captured using an Olympus BX41 light micro-
scope (Southend-on-Sea, UK) and QIcam Fast 1394 (QImaging,
BC, Canada) and Image Pro Plus 6.0 (Media Cybernetics Inc,
MD, USA). For every section, 10 random images of terminal villi
were taken, giving a total of 30 images per placenta for each
component evaluated.
Assessment of Placental Structure
Macroscopic placental structure was assessed using Image
ProPlus 6.0 Software. The surface area, maximum, minimum
and mean diameter, and percentage of placenta are with abnormal
pale appearances were measured from photographs using the ‘area
of interest’ tool; these were also confirmed to be pale on the cut
surfaces of the placenta. A measure of placental roundness was
calculated and cord insertions were determined through analysis of
the photographs and classified using an established system, as
follows: central, eccentric, marginal or velamentous [26].
Microscopic structure was evaluated as follows: the number of
syncytial knots were counted and total villous area measured using
image analysis software (Image ProPlus 6.0), expressed as the
number of syncytial knots per mm
2 of villous tissue as previously
described [19]. Proliferative index was the number of Ki67
positive nuclei as a proportion of total nuclei as previously
described [27]. Apoptosis was assessed by the number of nuclei
surrounded by cytoplasmic M30 staining as proportion of total
nuclei in the image. Vascularity was expressed as the number of
capillaries per terminal villus. Trophoblast area was expressed as
the proportion of villous area positive for CK-7 immunostaining.
In addition to quantitative analysis placental tissue stained with
haematoxylin and eosin was assessed by a perinatal histopathol-
ogist (GB) who was blinded to the outcome of pregnancy. For each
placenta three samples were analysed, and were qualitatively
assessed for the presence of infarction, excessive syncytial knots,
distal villous hypoplasia, villous immaturity, villitis and other
incidental abnormalities.
Placental System A uptake activity
Placental villous fragments (,3–4 mm
3) were incubated in a
solution of radiolabelled-N-methylated aminoisobutyric acid (
14C-
MeAIB) (0.5 mCi/ml; 8.5 mM) (Perkin-Elmer, Cambridge, Cam-
bridgeshire) with either control Tyrode’s or Na
+-free Tyrode’s
[NaCl replaced with 135.0 mM/L choline chloride] buffer for 30,
60 or 90 minutes at 37uC as previously described [28]. After
incubation, the explants were lysed in dH20 for 16–18 hours at
room temperature. The radioactive content of the water was
measured using a b-scintillation counter. The protein content of
each villous fragments was determined by placing the tissue in
0.3 M NaOH for a minimum of 6 hours at 37uC, then using the
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counts were corrected for protein content. As System A is Na
+-
dependent, its activity was calculated by subtracting uptake in
Na
+-free Tyrode’s from that in control Na
+-containing Tyrode’s.
Statistical analysis
Power calculations were performed using PS Power and Sample
Size Calculation (Version 3.0, January 2009). Power calculations
were based on our previous data on syncytial knot density [19] and
apoptosis [29] as data were not available for other indices. For a
90% power and an alpha value of 0.05, 6 experimental samples
would be required to show a significant difference in the number
of syncytial knots and 12 experimental samples would be required
to show a significant difference in apoptosis between control
pregnancies and RFM ending in a poor pregnancy outcome. As
we anticipated that between 25–33% of our placental samples
would have a poor pregnancy outcome, 24–36 subjects with RFM
would be required for an adequately powered study.
Statistical analysis was performed using GraphPad Prism 4.0
(GraphPad Software, La Jolla, CA, USA) and Joosse Online
Statistics http://in-silico.net/statistics/fisher_exact_test. Normali-
ty of the data was first tested using the Kolmogorov-Smirnov test.
For normally distributed continuous data, Student’s t test was
used, and for non-normally-distributed continuous data Mann
Whitney U Test was used. For analysis of more than 2 data sets
Kruskal-Wallis with Dunn’s post-hoc test was used (non-paramet-
ric). Categorical data were tested using Fishers’ exact test. System
A activity was assessed by two-way ANOVA.
Results
Demographic data
During the study period 7,651 women gave birth at St Mary’s
Hospital. Of these 351 presented to the maternity day unit with
RFM, of whom 305 agreed to participate in the study. 36
participants gave birth within 7 days of assessment. Table 1 shows
the demographic data for women with RFM and control
pregnancies from whom placental tissue was collected. There
was no significant difference in other maternal demographic
details, gestation, or induction of labour. Women in the control
group were more likely to have had elective Caesarean section.
Twelve women (33%) with RFM had a poor pregnancy
outcome, 8 were SGA at term, 3 were SGA born preterm, and
one was preterm with a normal birthweight. The birthweight
centile is skewed towards the lower values in women with RFM
(RFM median 15 (range 0–100) compared to control 51 (12–96)),
reinforcing the association between RFM and SGA. Six of the 12
patients with poor outcome after RFM had evidence of placental
pathology at the time of initial assessment (oligohydramnios,
abnormal umbilical artery Doppler). All participants with normal
outcome after RFM had normal estimated fetal weight, liquor
volume and umbilical artery Doppler at initial assessment.
Placental structure
Macroscopic changes in placental structure were evident in
RFM compared to control pregnancies (Table 2). In comparison
to normal pregnancies, placentas from RFM are lighter, have a
smaller surface area, a higher fetal-placental weight ratio and a
greater proportion taken up with abnormal appearing white areas
(Figure 1) which were also visible on cut surface of the placenta.
They are also more likely to have a non-central cord insertion. To
evaluate whether this effect was primarily due to pregnancies with
poor pregnancy outcome, a further analysis was performed
comparing normal pregnancies to RFM with a normal outcome
and to RFM with a poor outcome. This demonstrated that only
placentas from RFM with a poor outcome had a smaller placental
weight and size than normal controls. However, the fetal:placental
Table 1. Demographic details of subjects with RFM.
RFM (n=36) Normal (n=36) P value
Maternal age 27 yrs (17–41) 30 yrs (18–41) 0.10
Gravidity 2 (1–8) 2 (1–7) 0.86
Parity 1 (0–4) 1 (0–6) 0.55
Body Mass Index 24.4 (18.1–45.6) 24.6 (17.8–41.9) 0.88
Gestation at delivery 40
+1 (30
+1–42
+0)4 0
+1 (37
+4–42
+2) 0.18
Cigarette Smoking 8 (22.2%) 5 (13.9%) 0.54
{
Pre-existing complications in Pregnancy* 4 (11.1%) 0 (0%) 0.11
{
Evidence of fetal Estimated fetal weight ,10
th centile 8
# (22.2%) -
compromise at Abnormal umbilical artery Doppler 1
# (2.7%) -
presentation with RFM Abnormal cardiotocography trace 1
# (2.7%) -
Recurrent presentation with RFM 7 (19.4%) -
Induction of Labour 10 (27.7%) 4 (11.1%) 0.08
{
Caesarean Section 9 (25.0%) 21 (58.3%) 0.008
{
Birthweight centile 15.3 (0–100) 58.5 (12–98) P,0.0001
{***
Poor pregnancy outcome** 12 (33.0%) 0 (0%) p,0.005
{**
Admission to NICU 3 (8.3%) 1 (2.8%) 1.00
{
Continuous data are presented as medians with range in parentheses.
#One participant had estimated fetal weight ,10
th centile, abnormal umbilical artery Doppler and abnormal fetal heart rate trace.
*Complications in pregnancy included oligohydramnios and gestational diabetes.
**Poor pregnancy outcome defined as birthweight ,10
th centile, delivery before 37 weeks gestation or admission to the neonatal intensive care unit (NICU).
{Differences between proportions tested using Fishers’ exact test.
doi:10.1371/journal.pone.0034851.t001
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and the number of placentas with non-central cord insertion
differed between normal controls and RFM irrespective of the
outcome of pregnancy.
Qualitative histopathological examination showed that samples
from RFM more often had excessive syncytial knots (p,0.001)
and infarction (p,0.01) (Table 3). All samples from RFM showed
excessive syncytial in at least one area of the placenta. The areas
affected by infarction showed early changes of ischaemia. Other
abnormalities identified in RFM included: chronic villitis (focal),
patchy hydropic changes and chorangiosis.
When quantifying changes in microstructure, there was
significantly reduced villous vascularity and syncytiotrophoblast
area in RFM but increased density of syncytial knots (Figure 2 A–
C) and proliferative index (Figure 2E). There was no difference in
rates of apoptotic cell death as assessed by M30 immunostaining
(Figure 2D). When the RFM group was divided according to
pregnancy outcome significant differences in microscopic placental
structure were observed between normal control pregnancies and
RFM with both normal and poor pregnancy outcome (Figure 3).
A correlation between cases with abnormal CTG,oligohydramnios
or abnormal umbilical artery Doppler and the microscopic analyses in
placentas from pregnancies with RFM is not possible due to the small
numbers of these abnormalities. However, the relationship between
birthweight centile and the microscopic indices was assessed. There
was no significant correlation between birthweight centile and the
density of syncytial knots, apoptotic index, proliferative index or the
number of vessels per villus. There was a positive correlation between
trophoblast area (r
2=0.12, p=0.04) and placental weight (r
2=0.32,
p=0.003) with birthweight centile.
System A amino acid transporter activity
The activity of the system A amino acid transporter was
analysed in 12 placentas from pregnancies associated with RFM
and 12 placentas from uncomplicated pregnancies (Figure 4). In
the presence of Na
+ 14CMeAIB uptake increases over time in both
Figure 1. Examples of placental photographs from uncomplicated (A–B) and RFM (C–D) pregnancies. A) Fetal side of a control placenta
with a central cord insertion and normal distribution of chorionic plate vessels. B) Shows the maternal side of a control placenta. C) Shows the fetal
side of a RFM placenta which is less round than the control example, and the cord is inserting laterally. D) Shows the maternal side of a RFM placenta.
The area highlighted by the yellow line shows an abnormal white area which was confirmed on the cut surface of the placenta.
doi:10.1371/journal.pone.0034851.g001
Table 3. Classification of samples on histopathological review.
Histological Feature Normal (n=18) Reduced Fetal Movements (n=36) p value
No samples 1–2 samples All samples No samples 1–2 samples All samples
Infarction 18 (100) 0 (0) 0 (0) 25 (69) 11 (31) 0 (0) 0.01
Excessive Syncytial Knots 8 (45) 6 (33) 4 (22) 0 (0) 10 (28) 26 (72) ,0.0001
Distal Villous Hypoplasia 11 (61) 5 (28) 2 (11) 13 (36) 18 (50) 5 (14) 0.24
Villous Immaturity 16 (89) 2 (11) 0 (0) 31 (86) 2 (6) 3 (8) 0.56
Villitis 18 (100) 0 (0) 0 (0) 34 (94) 2 (6) 0 (0) 0.11
Other 18 (100) 0 (0) 0 (0) 32 (89) 4* (11) 0 (0) 0.28
Statistical significance tested using Fisher’s exact test.
*=2 patchy hydropic villi and 2 chorangiosis. % of total samples is shown in brackets for each feature assessed.
doi:10.1371/journal.pone.0034851.t003
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34851Figure 2. Microscopic structure of RFM placentas compared to control pregnancies. A) RFM placentas have significantly decreased villous
vascularity (*** p,0.001, Mann-Whitney U test). Representative micrographs of CD31 immunostaining. B) In RFM, the placenta has significantly
reduced trophoblast area compared to control placentas (**p,0.01, Mann Whitney U Test). Representative micrographs of CK7 immunostaining. C)
Density of syncytial knots is increased in RFM (*** p,0.001, Mann-Whitney U Test). Representative images from haematoxylin and eosin staining,
syncytial knots are marked with arrows. D) There is no significant difference in cell death through apoptosis in RFM compared to control placentas.
Representative images from M30 staining; M30 staining is marked with arrows. E) Proliferative Index is increased in RFM (**p,0.01, Mann-Whitney U
Test) Representative images from Ki67 immunostaining (Mib1 antigen). Positive nuclei are marked with arrows. In all photomicrographs bar=50 mm.
doi:10.1371/journal.pone.0034851.g002
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34851control and RFM placentas (Figure 4A) and uptake is higher than
in the absence of Na
+. The Na
+-dependent component of
14CMeAIB uptake (System A activity) is significantly reduced in
placental villous explants from pregnancies associated with RFM,
when compared to samples taken from uncomplicated pregnancies
(Figure 4B). The reduction in system A activity was even more
pronounced in women with RFM associated with a poor
pregnancy outcome (n=3) (Figure 4B).
Discussion
Placentas from women who reported RFM within a week of
delivery had significant differences in placental structure and
function when compared to placentas taken from uncomplicated
pregnancies with normal movements. These changes in the
structure and function of the placenta are similar to the hallmarks
of placental insufficiency in SGA [19,30,31]. For example, the
increase early placental changes of infarction was reminiscent of
changes present in stillbirths with SGA [32]. Abnormalities in cord
insertion were also evident in RFM and are similar to observations
made by Biswas and Ghosh in SGA pregnancies [26]. This
combination of lateral cord insertion and abnormal placental
shape has been proposed by Salafia et al. to lead to reduced
placental efficiency, possibly due to alterations of placental
vascularity and branching [33,34], providing a mechanism linking
abnormal placental shape with RFM, SGA and stillbirth.
Figure 3. Microscopic structure of RFM placentas split by those with normal and poor pregnancy outcomes (PPO). demonstrating that
the same pattern in abnormal villous structure is present in all women with RFM with respect to: A) Villous vascularity B) Trophoblast area C) Density
of syncytial knots D) Apoptosis E) Proliferative Index. (* p,0.05, **p,0.01, ***p,0.001, Kruskal-Wallis Test).
doi:10.1371/journal.pone.0034851.g003
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34851There have been no studies of apoptosis, proliferation and
trophoblast area in stillbirths to enable comparison with the data
from RFM. However, RFM was associated with several
abnormalities of placental villous architecture including reduced
villous vascularity and reduced area of the trophoblast in the
terminal villi. Reduced villous vascularity has been previously
found in SGA and stillbirth [14,32]. Likewise, syncytiotrophoblast
area has been correlated with birthweight and is reduced in SGA
[30]. The combination of these anomalies will reduce the
functional capacity of the placenta thereby decreasing the supply
of oxygen and nutrients to the fetus, resulting in SGA. The density
of syncytial knots was greatly increased in RFM compared to
normal placental samples which agrees with previous work that
has shown increased syncytial knots in placental pathologies such
as SGA and pre-eclampsia [35,36]. These quantitative changes in
syncytial knots were present in placentas from RFM irrespective of
the pregnancy outcome and were confirmed by histopathological
assessment of the placenta. Taken together the macroscopic and
microscopic changes suggest that there is a degree of abnormal
placental structure associated with RFM per se.
The abnormalities in villous structure are coupled with altered
placental function in RFM. The activity of the System A amino
acid transporter has been consistently shown to be reduced in
placentas from women suffering SGA or FGR [21,31] and was
used here as a marker of placental nutrient transport function. The
reduction in System A activity in placentas from women reporting
RFM suggests that there is a degree of functional impairment in
these placentas, alongside the structural abnormalities. Future
studies will need to examine other aspects of placental function
that might be altered in women reporting RFM.
As with all studies, this study has some limitations. Firstly, there
is a potential for selection bias, if women presenting with RFM
were only from high-risk pregnancies that had been told to
monitor fetal movements closely, then this might bias the sample
towards those with placental pathology. In fact, only 4 cases (11%)
of RFM had pre-existing maternal or fetal complications making
this possibility unlikely. Secondly, placental tissue was only
collected from women who delivered within one week of
presenting with RFM. This may have favoured collection of tissue
from pregnancies which were induced or delivered for complica-
tions. However, to have obtained all placental tissue would make it
difficult to link RFM in the early third trimester with placenta
pathology evident at delivery at term. Thirdly, the inclusion of
preterm delivery preterm may have altered the results as placental
pathology may be different in preterm and term SGA. In total, 4
(11%) cases of RFM were preterm, and even when these cases are
excluded the differences in placental microstructure are still
evident. The mode of delivery may have affected the aspects of
placental cell turnover and system-A transport. However, in these
experiments, analysis of samples from women who had Caesarean
section versus Vaginal Delivery showed no difference in
microscopic placental structure or system A activity.
None of the women recruited to the study or this placenta
cohort had pregnancies resulting in stillbirth. This may in part be
due to participation in a clinical study (the Hawthorne effect) or
the improved standardised care that all women recruited onto the
study received so that signs of fetal compromise were managed
appropriately. Thus, structural changes in the placenta in stillbirth
after RFM have not been investigated. Through subdividing the
RFM group into those with normal outcome and those with poor
pregnancy outcome it has been possible to show that the
abnormalities seen cannot solely be attributed to those placentas
associated with overt pathology, where structural abnormalities
are well documented. This provides evidence to confirm the study
hypothesis, and to suggest that in some women RFM is associated
with a degree of placental insufficiency.
These data linking RFM with changes to placental structure and
impaired amino acid transport suggest that women presenting with
RFM should be taken seriously and assessed carefully to identify
evidence of placental insufficiency; specifically acute fetal com-
promise or FGR/SGA. Current tests to identify placental
insufficiency include clinical assessment of fetal size by measure-
ment of symphysiofundal height through to ultrasound biophysical
profiles but strategies are used inconsistently [25,37,38]. Currently,
there is little evidence to demonstrate which test (if any) has
sufficient sensitivity or specificity to identify babies at the highest
risk of stillbirth to direct intervention [25]. Given the evidence of
placental insufficiency in some women with RFM, a placental
biomarker may be a useful predictor of poor pregnancy outcome
in this group. A study is underway to measure such placental
biomarkers and determine their efficacy in predicting poor
pregnancy outcome in a cohort of women presenting with RFM.
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